MedPath

NRS 2002 as a Predictor of Prognosis in COPD With Respiratory Failure

Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Respiratory Insufficiency
Registration Number
NCT02942797
Lead Sponsor
West China Hospital
Brief Summary

This is a prospective study of patients diagnosed with chronic obstructive pulmonary disease (COPD) with respiratory failure and admitted in West China Hospital during April 2017 to March 2019. The following variables will be prospectively studied: age, sex, height, weight, respiratory function indicators, arterial blood gas analysis results, biochemical data, nutritional risk screening 2002 (NRS 2002) score, short-term and long-term prognostic outcomes. The purpose of this study is to assess whether NRS 2002 is a useful prognosis predictor in COPD patients with respiratory failure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
520
Inclusion Criteria
  • Newly diagnosis of COPD at West China Hospital during April 2017 to March 2019
  • Partial pressure of O2 (PaO2) < 60 mmHg and/or partial pressure of CO2 (PaCO2) >50 mmHg
  • Age ≥ 18 years
  • Respiratory rates > 23 bpm
Exclusion Criteria
  • Pregnancy or during lactation
  • Ventilatory dysfunction due to neuromuscular disorders, acute and chronic thromboembolic disease, severe illness in other systems
  • Refused to participate in this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Predictive value of NRS 2002 in identifying COPD patients with respiratory failure who will have poor prognostic outcomes, in terms of mortalityup to 2 years
Predictive value of NRS 2002 in identifying COPD patients with respiratory failure who will have poor prognostic outcomes, in terms of complicationsup to 2 years
Predictive value of NRS 2002 in identifying COPD patients with respiratory failure who will have poor prognostic outcomes, in terms of length of stayup to 2 years
Predictive value of NRS 2002 in identifying COPD patients with respiratory failure who will have poor prognostic outcomes, in terms of 30-day readmission after dischargeup to 2 years
Secondary Outcome Measures
NameTimeMethod
Collection of Demographics (age, sex)up to 2 years

Trial Locations

Locations (1)

West China Hospital

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath